TRUSYNERGY

Lobbying for BURRELL INTERNATIONAL GROUP (ON BEHALF OF AMO PHARMA) · Life Sciences R&D

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 14, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Rare Disease Policy and FDA Policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.